Quantcast
Global Blood Therapeutics Inc (NASDAQ: GBT) | The Mesh Report

Global Blood Therapeutics Inc (NASDAQ: GBT)

Christian Tharp, CMT March 16, 2020 Comments Off on Global Blood Therapeutics Inc (NASDAQ: GBT)

Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. 

Take a look at the 1-year chart of GBT (NASDAQ: GBT) with the added notations:

1-year chart of GBT (NASDAQ: GBT)

GBT has formed an important level of support at $45 (green) over the past several months. After a two-month long decline, the stock has fallen back down to that support. If the $45 level were to break, lower prices should follow for GBT.

The Tale of the Tape: GBT has key support at $45. A trader could enter a long position at or around $45 with a stop placed under the level. If the stock were to break below the support, a short position could be entered instead.

Before making any trading decision, decide which side of the trade you believe gives you the highest probability of success. Do you prefer the short side of the market, long side, or do you want to be in the market at all? If you haven’t thought about it, review the overall indices themselves. For example, take a look at the S&P 500. Is it trending higher or lower? Has it recently broken through a key resistance or support level? Making these decisions ahead of time will help you decide which side of the trade you believe gives you the best opportunities.

No matter what your strategy or when you decide to enter, always remember to use protective stops and you’ll be around for the next trade. Capital preservation is always key!

Good luck!
Christian Tharp, CMT



Comments are closed.